Biotech Labz Supply Expands Research Peptide Catalog with 11 Documented Compounds

By SoCal Editorial Team
Biotech Labz Supply Inc has expanded its online catalog to include 11 research peptides, all accompanied by batch-specific COA documentation, supporting controlled laboratory investigations.
Biotech Labz Supply Expands Research Peptide Catalog with 11 Documented Compounds

Biotech Labz Supply Inc, a California-based online supplier of research peptides, has announced the expansion of its catalog to include 11 documented research compounds, providing qualified researchers and laboratory professionals with a broader selection of high-purity peptides.

The expanded catalog now includes BPC-157, TB-500, GHK-Cu, CJC-1295, Ipamorelin, Tesamorelin, MOTS-c, Semaglutide, Tirzepatide, Retatrutide, and NAD+ peptides, among other laboratory research compounds. All products are designated strictly for research use only and are not intended for human or animal consumption, diagnostic, therapeutic, or clinical application.

This expansion addresses the growing need for reliable sourcing of research peptides. By offering a wider range of compounds through a single supplier, Biotech Labz Supply aims to streamline procurement for authorized scientific work, covering applications such as receptor-binding studies, biochemical pathway research, and compound characterization.

One of the key features of this catalog is the inclusion of batch-specific peptide COA (Certificate of Analysis) documentation. This documentation allows researchers to review the identity and purity of each batch before incorporating it into approved research protocols. Depending on the compound, the COA may include product identity, reported purity results, batch or lot identification, analytical testing information, testing dates, storage information, and available laboratory results.

Researchers are encouraged to review the peptide COA supplied with each product and independently determine its suitability for their specific research methods, equipment, and institutional requirements.

The availability of these compounds supports various active research areas. For instance, BPC-157 and TB-500 are used in controlled peptide characterization and tissue-response pathway studies, while GHK-Cu is relevant for copper-binding peptide chemistry and cellular-signaling pathways. CJC-1295, Ipamorelin, and Tesamorelin are offered for research involving peptide structure, receptor activity, and growth-hormone-related signaling mechanisms. Semaglutide, Tirzepatide, and Retatrutide are available for metabolic peptide research, focusing on receptor-binding behavior and metabolic-signaling pathways. MOTS-c is for mitochondrial peptide studies, and NAD+ peptides are for cellular energy pathway research.

Biotech Labz Supply emphasizes that these descriptions are for general research areas only and do not imply safety, effectiveness, or medical benefits.

The company's online platform allows qualified customers to review product information and COA documentation before procurement. It serves qualified laboratory researchers, academic institutions, biotechnology organizations, commercial research facilities, analytical laboratories, and authorized scientific professionals.

Biotech Labz Supply retains the right to restrict or refuse transactions inconsistent with its research-only policies. Products cannot be purchased for self-administration, compounding, diagnosis, treatment, or any human or veterinary application.

This expansion reflects the company's commitment to strengthening research-supply standards by emphasizing product identification, batch traceability, analytical documentation, and clear labeling. Researchers are reminded to ensure all activities comply with applicable laws and institutional policies.

For more information and to review the full catalog, visit https://biotechlabzsupply.com/.

SoCal Editorial Team

SoCal Editorial Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.